Cargando…
Ca(2+)-Dependent Effects of the Selenium-Sorafenib Nanocomplex on Glioblastoma Cells and Astrocytes of the Cerebral Cortex: Anticancer Agent and Cytoprotector
Despite the fact that sorafenib is recommended for the treatment of oncological diseases of the liver, kidneys, and thyroid gland, and recently it has been used for combination therapy of brain cancer of various genesis, there are still significant problems for its widespread and effective use. Amon...
Autores principales: | Varlamova, Elena G., Khabatova, Venera V., Gudkov, Sergey V., Turovsky, Egor A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917080/ https://www.ncbi.nlm.nih.gov/pubmed/36768736 http://dx.doi.org/10.3390/ijms24032411 |
Ejemplares similares
-
Cytoprotective Properties of a New Nanocomplex of Selenium with Taxifolin in the Cells of the Cerebral Cortex Exposed to Ischemia/Reoxygenation
por: Varlamova, Elena G., et al.
Publicado: (2022) -
Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, “Naked” Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells
por: Varlamova, Elena G., et al.
Publicado: (2022) -
Pilot Study of Cytoprotective Mechanisms of Selenium Nanorods (SeNrs) under Ischemia-like Conditions on Cortical Astrocytes
por: Varlamova, Elena G., et al.
Publicado: (2023) -
The Protective Mechanism of Deuterated Linoleic Acid Involves the Activation of the Ca(2+) Signaling System of Astrocytes in Ischemia In Vitro
por: Turovsky, Egor A., et al.
Publicado: (2021) -
Size-Dependent Cytoprotective Effects of Selenium Nanoparticles during Oxygen-Glucose Deprivation in Brain Cortical Cells
por: Varlamova, Elena G., et al.
Publicado: (2022)